INTERNATIONAL PATENT: KEYTHERA (SUZHOU) BIO-PHARMACEUTICALS CO., LIMITED, 凯复（苏州）生物医药有限公司 FILES APPLICATION FOR "MRGPRX2 ANTAGONIST, PHARMACEUTICAL COMPOSITION COMPRISING SAME AND USE THEREOF"

Posted On: 2025-11-02

GENEVA, Nov. 2 -- KEYTHERA (SUZHOU) BIO-PHARMACEUTICALS CO., LIMITED (B2-508, Phase I Biomedical Industrial Park, Suzhou Industrial Park, 218 Xinghu StreetSuzhou, Jiangsu 215000), 凯复（苏州）生物医药有限公司 (中国江苏省苏州市苏州工业园区星湖街218号生物医药产业园一期项目B2楼508单元) filed a patent application (PCT/CN2025/079549) for "MRGPRX2 ANTAGONIST, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND USE THEREOF" on Feb 27, 2025. With publication no. WO/2025/223036, the...

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

INTERNATIONAL PATENT: KEYTHERA (SUZHOU) BIO-PHARMACEUTICALS CO., LIMITED, 凯复（苏州）生物医药有限公司 FILES APPLICATION FOR "MRGPRX2 ANTAGONIST, PHARMACEUTICAL COMPOSITION COMPRISING SAME AND USE THEREOF"